The progress in understanding and treatment of diabetic retinopathy AW Stitt, TM Curtis, M Chen, RJ Medina, GJ McKay, A Jenkins, ... Progress in retinal and eye research 51, 156-186, 2016 | 991 | 2016 |
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies EJ Duh, JK Sun, AW Stitt JCI insight 2 (14), 2017 | 962 | 2017 |
Neurodegeneration in diabetic retinopathy: does it really matter? R Simó, AW Stitt, TW Gardner Diabetologia 61, 1902-1912, 2018 | 484 | 2018 |
The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes A Stitt, TA Gardiner, NL Anderson, P Canning, N Frizzell, N Duffy, C Boyle, ... Diabetes 51 (9), 2826-2832, 2002 | 483 | 2002 |
Technical brief: Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR DAC Simpson, S Feeney, C Boyle, AW Stitt Mol. Vis 6, 178-183, 2000 | 465 | 2000 |
The pathology associated with diabetic retinopathy J Lechner, OE O'Leary, AW Stitt Vision research 139, 7-14, 2017 | 464 | 2017 |
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. AW Stitt, YM Li, TA Gardiner, R Bucala, DB Archer, H Vlassara The American journal of pathology 150 (2), 523, 1997 | 461 | 1997 |
Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. YM Li, T Mitsuhashi, D Wojciechowicz, N Shimizu, J Li, A Stitt, C He, ... Proceedings of the National Academy of Sciences 93 (20), 11047-11052, 1996 | 443 | 1996 |
Endothelial progenitors: a consensus statement on nomenclature RJ Medina, CL Barber, F Sabatier, F Dignat-George, JM Melero-Martin, ... Stem cells translational medicine 6 (5), 1316-1320, 2017 | 442 | 2017 |
Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities RJ Medina, CL O'Neill, M Sweeney, J Guduric-Fuchs, TA Gardiner, ... BMC medical genomics 3, 1-13, 2010 | 416 | 2010 |
Advanced glycation: an important pathological event in diabetic and age related ocular disease AW Stitt British journal of ophthalmology 85 (6), 746-753, 2001 | 416 | 2001 |
Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? TM Curtis, TA Gardiner, AW Stitt Eye 23 (7), 1496-1508, 2009 | 385 | 2009 |
Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. U Chakravarthy, RG Hayes, AW Stitt, E McAuley, DB Archer Diabetes 47 (6), 945-952, 1998 | 330 | 1998 |
The role of advanced glycation in the pathogenesis of diabetic retinopathy AW Stitt Experimental and molecular pathology 75 (1), 95-108, 2003 | 323 | 2003 |
AGEs, RAGE, and diabetic retinopathy H Zong, M Ward, AW Stitt Current diabetes reports 11, 244-252, 2011 | 295 | 2011 |
Current understanding of the molecular and cellular pathology of diabetic retinopathy DA Antonetti, PS Silva, AW Stitt Nature Reviews Endocrinology 17 (4), 195-206, 2021 | 287 | 2021 |
The role of advanced glycation end products in retinal microvascular leukostasis TCB Moore, JE Moore, Y Kaji, N Frizzell, T Usui, V Poulaki, IL Campbell, ... Investigative ophthalmology & visual science 44 (10), 4457-4464, 2003 | 271 | 2003 |
Differentiation of human pluripotent stem cells to cells similar to cord-blood endothelial colony–forming cells N Prasain, MR Lee, S Vemula, JL Meador, M Yoshimoto, MJ Ferkowicz, ... Nature biotechnology 32 (11), 1151-1157, 2014 | 267 | 2014 |
AGEs and diabetic retinopathy AW Stitt Investigative ophthalmology & visual science 51 (10), 4867-4874, 2010 | 265 | 2010 |
Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. AW Stitt, TA Gardiner, DB Archer British Journal of Ophthalmology 79 (4), 362-367, 1995 | 252 | 1995 |